What is Stenabolic sr9009?
Stenabolic SR9009 is a synthetic compound known for its diverse biological activities. It acts as an activator of REV-ERBs, proteins that regulate the body's internal clock. SR9009 has been shown to improve exercise tolerance and control skeletal muscle mass through metabolic modulation. This compound is widely available online as a 'supplement' due to its potential performance-enhancing effects and presents a significant concern in the context of doping control in sports [1].
Mechanism of Action and Legality
SR9009 and its analogues have been studied for their effects on glycolipid metabolism. They have been found to improve exercise tolerance and lower blood lipid levels in hyperlipidemic mice, displaying stronger hypoglycaemic activity than SR9009 [2].
Despite its potential benefits, SR9009 has yet to receive approval from the United States Food and Drug Administration (USFDA). It has been classified as a prohibited substance by the World Anti-Doping Agency and the International Federation of Horseracing Authorities (IFHA) due to concerns about its illegal distribution [3].
Benefits of SR9009
One of the key benefits of SR9009 is its ability to improve exercise tolerance. This means it can enhance your ability to engage in physical activities for longer periods without getting tired [2].
Another significant benefit of SR9009 is its potential to control skeletal muscle mass. This can be particularly beneficial for individuals looking to build or maintain muscle mass [2].
SR9009 has also shown promise in managing glycolipid metabolism. In hyperlipidemic mice, SR9009 and its analogues improved exercise tolerance and lowered blood lipid levels. This suggests that SR9009 could be beneficial in managing conditions related to lipid metabolism, such as high cholesterol or triglyceride levels.
Side effects of SR9009
As SR9009 is not an approved medication, there is limited data on its side effect profile in humans. Some potential side effects that have been noted in animal studies of SR9009 and its analogues include:
Hypoglycemia (low blood sugar): SR9009 analogues 5m and 5p displayed stronger hypoglycemic activity compared to SR9009 in mice [2]. Hypoglycemia, if severe, can potentially cause symptoms like shakiness, confusion, and loss of consciousness.
It's important to note that as an experimental compound, SR9009 would require more rigorous safety testing in humans to fully characterize its side effect profile. The limited data available is mainly from animal and in vitro studies.
Given the lack of human clinical trials, the safety of using SR9009 in humans has yet to be established. Its side effects could be serious. If Considering this compound, consulting with a medical professional to weigh the potential risks and benefits is critical.
Safety
Given the lack of human clinical trials and the potential for unknown side effects, it's recommended to exercise caution when considering the use of SR9009. Always consult with a healthcare provider before starting any new supplement or medication.